Navigation Links
Parker Waichman Alonso LLP, Becnel Law Firm, LLC, Douglas & London P.C., Levin
Date:1/17/2008

Simes Kaiser and Gornick LLP, Bailey Perrin Bailey LLP and Weitz & Luxenberg, P.C., Have Filed a Class Action Lawsuit Today in the United States District Court for the Eastern District of New York Against Merck &

Co., Inc. and Schering-Plough Corporation.

GREAT NECK, N.Y., Jan. 17 /PRNewswire/ -- On January 17, 2008, the law firms of Parker Waichman Alonso LLP, Becnel Law Firm, LLC, Douglas & London P.C., Levin Simes Kaiser and Gornick LLP, Bailey Perrin Bailey LLP and Weitz & Luxenberg, P.C., filed a Class Action lawsuit in Federal District Court, Eastern District of New York, Docket #08-258 before The Honorable Carol Bagley Amon, Judge of the United States Eastern District Court of New York, against Merck & Co., Inc. and Schering-Plough Corporation. The class action seeks, in part, refunds to individuals who were prescribed and purchased the popular cholesterol statin drug, Vytorin(R). Vytorin(R) is a single pill combination of two drugs, Zocor and Zetia, (ezetimibe plus simvastatin).

The lawsuit alleges that Merck & Co., Inc. and Schering-Plough Corporation, the manufacturers of the prescription drug, Vytorin(R), made misrepresentations and withheld significant information in its approval submissions and filings with the Federal Drug Administration. It is also alleged that misrepresentations were made to the general public through marketing efforts as to the effectiveness of the drug. In reality, studies have shown that it is no better than other available drugs on the market in lowering cholesterol.

The above law firms have been contacted and retained by many individuals, including the proposed class representative, who have been prescribed and used Vytorin(R) and who are seeking refunds for their prescriptions.

Contact:

PARKER WAICHMAN ALONSO LLP, +1-516-466-6500


'/>"/>
SOURCE PARKER WAICHMAN ALONSO LLP
Copyright©2008 PR Newswire.
All rights reserved

Page: 1

Related medicine news :

1. Parker Waichman Alonso LLP, Along with Smith & Nevares, Salas & Co. and Becnel
2. MaxLife Fund Corp. retains the Law firm, Anslow & Jaclin, LLP of Manalapan, N.J., to review MaxLife Fund Corp. options to be listed on the NASDAQ Capital Market
3. Ventas Board Names Ronald G. Geary Audit Committee Chair; Appoints Douglas Crocker II to Fill Vacancy on Audit Committee
4. American Cancer Society to Present Highest Honor to Matthew L. Myers, Douglas R. Lowy, and Mark Schiffman for Outstanding Contributions to Cancer Fight
5. London School of Hygiene to play key role in global collaboration on adverse drug reactions
6. Prime Minister views innovative health technology at Imperial College London
7. Capps to Lead Bipartisan Womens Caucus Congressional Delegation to Represent United States at Women Deliver Conference in London
8. Prestigious London Hospital Enters Long-Term Agreement with Varian Medical Systems
9. DaVita Nurse Gives Keynote Speech to St. Georges Hospital Vascular Access Annual Meeting in London
10. Baron & Budd, P.C., Announces $3.6 Million Settlement in California Asbestos Lawsuit
11. Former Texas Assistant Attorney General Pat OConnell Joins Baron & Budd, P.C., to Lead Whistleblower Litigation Practice

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...e/--TwomoreH1N1vaccineclinicshavebeenscheduledforT...thDepartmentannouncedtoday.Theyarebeingofferedatno...rlingHeights. ,, TheDec.3clinicwillbeheldfromno...merosol-freeversionoftheinjectablevaccinewillbeava...andnasalsprayimmunizationwillbeoffered.Pregnantwom...
(Date:11/25/2009)...ntial to normal human development - the Wnt/Wingle...R) pathways - interact in ways that can promote tu... The University of Texas M. D. Anderson Cancer Cen... . , This newly characterized interaction involv...ith invasive cancer - activation of EGFR, elevated...
(Date:11/25/2009)... , An innovative treatment for HIV patients ...rchers has passed its first clinical trial with fl... customized for each individual patient, and was d...tute of the MUHC in collaboration with Dr. R. Skal...e made for the individual patient an "haute coutu...
(Date:11/25/2009)... to enjoy festive feasting , , WEDNESDAY...-week holiday smorgasbord from Thanksgiving to New... pounds you,ll have to sweat off come Jan. 1, help...erts, to enjoy holiday eating and make it to 201...l about devising a strategy and thinking about hol...
(Date:11/25/2009)...wswire/--/EINNews/EINNews,anonlineleaderinindustry...esthealth-relatedpublicationforindustryprofessiona...om ). ,, H1N1NewsTodaygathersthelatestinformati...andresearchcenterstheworldover,searchingbeyondthef...ithreportsfromeverystateandeverycountry. ,, Dig...
Breaking Medicine News(10 mins):Health News:Macomb County Health Department Schedules Two More H1N1 Flu Vaccine Clinics Dec. 3 and 5 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:Tailor-made HIV/AIDS treatment closer to reality 2Health News:Holiday Eating Without the Guilt -- or the Pounds 2Health News:Holiday Eating Without the Guilt -- or the Pounds 3Health News:H1N1 News Today Examines the Swine Flu Virus From a Global Perspective; Read the Latest H1N1 Virus Vaccine & Prevention News From EIN News 2
...ations are rising and tough to get rid of, experts...) -- Although bed bugs might prevent you from slee...n,t appear to transmit illness, a new report finds...the Journal of the American Medical Association ,...
...sful Collaboration with the U.S. Army , , - U.S. ...ell,s first marketed product, a new vaccine agains...litary personnel , , - Success of Intercell,s new...act for IXIARO with the U.S. military, to be concl...
...e,s periapproval services experts to discuss REMS ...ETON, N.J., March 31 Covance Inc. (NYSE: CVD ...ment and risk evaluation and mitigation strategies...ce president of medical affairs for periapproval s...
...ON , March 31 The following is a statement from...merica,s Health (TFAH): , , Today,s recall of pis...ur food safety system is. Our current food safety ...urced, and understaffed. It is encouraging that th...
...y Tracking Tools Bring Women Together To Share and... March 31 23andMe , Inc., an industry leader i...aunched a free pregnancy community and research ...all women. , , Moms of all ages are welcome to pa...
... ConsumerLab.com Uncovers Defects ...d Finds Most Children,s Multivitamins Exceed Toler...s, New York (PRWEB) March 31, 2009 -- Over 30% of ...inated with lead. In addition, several products (i...
Other Medicine News:Health News:Bed Bugs Bring No Disease Danger 2Health News:Bed Bugs Bring No Disease Danger 3Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 2Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 3Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 4Health News:Intercell Announces FDA Approval of IXIARO(R), a Vaccine Against Japanese Encephalitis 5Health News:Covance Experts to Present Key Insights on Risk Management at Bio/Pharmaceutical Drug Safety Forum 2Health News:Covance Experts to Present Key Insights on Risk Management at Bio/Pharmaceutical Drug Safety Forum 3Health News:Trust for America's Health on the Recall of Certain Pistachios and the U.S. Food Safety System 2Health News:23andMe Launches Free Online Community for Moms and Moms-to-Be 2Health News:23andMe Launches Free Online Community for Moms and Moms-to-Be 3Health News:ConsumerLab.com Warns of Problems with Mulitivitamins and Vitamin Water 2Health News:ConsumerLab.com Warns of Problems with Mulitivitamins and Vitamin Water 3Health News:ConsumerLab.com Warns of Problems with Mulitivitamins and Vitamin Water 4Health News:ConsumerLab.com Warns of Problems with Mulitivitamins and Vitamin Water 5
(Date:11/24/2009)...irstCall/--AnadysPharmaceuticals,Inc.(Nasdaq: ANDS...perJaffrayHealthcareConferenceonTuesday,December1,...gheldatTheNewYorkPalaceHotel.SteveWorland,Ph.D.,Pr...eanoverviewofAnadysanditsclinicaldevelopmentprogra...willbesimultaneouslywebcastandcanbeaccessedontheIn...
(Date:11/24/2009)...wire/--ZargisMedicalCorp.,asubsidiaryofSpeedusCorp...search(NYSE: SI ),todayannouncedthatitsZargisCardi...fCBS, TheEarlyShow duringasegmentinwhichMarkJannot...inningproductsfromthepublication,s2009"BestofWhat,...elevisionmorningnewstalkshowbroadcastbyCBSfromNewY...
(Date:11/24/2009)...-USNewswire/--America,spharmaceuticalresearchandbi...estotreatorpreventHIV/AIDSandrelatedconditions,acc...ResearchandManufacturersofAmerica(PhRMA).December1...renesscampaignthatoriginatedatthe1988WorldSummitof..., "Wearegreatlyencouragedbythesecriticallyimport...
Breaking Medicine Technology:Anadys Pharmaceuticals to Present at the Piper Jaffray Healthcare Conference 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 2New Report Shows 97 Medicines and Vaccines Currently in Development for HIV/AIDS 3Top 10 Ways to Prevent or Delay Alzheimer 26apos 3Bs 60811 1Top 10 Ways to Prevent or Delay Alzheimer 26apos 3Bs 60811 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 1Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 2Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 3Novexel Starts Phase II Clinical Trial With NXL103 in Adults With Acute Bacterial Skin and Skin Structure Infections 28ABSSSI 29 6040 4ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 1ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 2ETEX Corporation Announces Distribution Agreement with Alphatec Spine 60809 3
...wswire/ -- Mersana, a,cancer therapeutics company,...es with its lead product candidate, XMT-1001, will...eting of the,American Association of Cancer Resear...s, CA. Full text of the abstracts can be,viewed on...f=,"http://www.aacr.org/">http://www.AACR.org . , ...
...e Oncology Compounds at the,American Association f...l., April 13, 2007 /PRNewswire-FirstCall/ -- For,d...hat target,cancer. Researchers now know that cance...y require new blood vessels to deliver oxygen,and ...,(proliferation), they travel throughout the body ...
Other Medicine Technology:Mersana Therapeutics, Inc. to Present Preclinical Data on XMT-1001,at American Association of Cancer Research Annual Meeting 2Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 2Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 3Abbott Researchers Focus on New Cutting-Edge Approaches in the,Fight Against Cancer 4
...nsfers depurinated DNA and RNA from agarose gels t...es ,Increases speed and efficiency of transfer by ...of an integrated system allowing electrophoresis, ... hours, versus 29 hours required for conventional ...
...nsfers depurinated DNA and RNA from agarose gels t...es ,Increases speed and efficiency of transfer by ...of an integrated system allowing electrophoresis, ... hours, versus 29 hours required for conventional ...
PosiBlot 30-30 Pads
Liquid Trap
Medicine Products: